BATF3 and colorectal carcinoma: In conclusion, silencing of SETDB1 could inhibit PD-L1 expression in CRC cells via the FOSB/miR-22/BATF3 axis and exerted the PD-L1/PD-1-mediated immunosuppression, leading to enhanced cytotoxicity of T cells.